Quick Answer
Petros Pharmaceuticals, Inc. reported Gross Profit of $3.90 million for fiscal year 2024.
Petros Pharmaceuticals, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $3.90M | -7.0% |
| 2023 | $4.19M | +13.2% |
| 2022 | $3.70M | -40.4% |
| 2021 | $6.21M | +12.7% |
| 2020 | $5.51M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $1.29M | +1.8% | +18.0% |
| June 30, 2024 | $1.09M | -26.2% | +3.3% |
| March 31, 2024 | $1.06M | -46.3% | -16.5% |
| September 30, 2023 | $1.27M | +172.6% | -14.5% |
| June 30, 2023 | $1.48M | -58.2% | -24.8% |
| March 31, 2023 | $1.97M | -1.3% | +212.8% |
| September 30, 2022 | -$1.74M | -195.5% | -149.3% |
| June 30, 2022 | $3.54M | +71.4% | +77.5% |
- Petros Pharmaceuticals, Inc. showed a decrease of -7.0% in Gross Profit compared to the prior fiscal year.
- Over the 2020–2024 period, Petros Pharmaceuticals, Inc.’s gross profit has declined by 29.3% (from $5.51 million to $3.90 million).
- The most recent figure is from Petros Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: